Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Sudaka

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Annales De Pathologie|November 8, 2011
[Sino nasal polyps: true and false tumors]Valérie Costes, Anne Sudaka, Michel Wassef
Thyroid : Official Journal of the American Thyroid Association|September 24, 2009
Synchronous parathyroid and papillary thyroid carcinomasPierre-Yves Marcy, Juliette Thariat, Anne Sudaka, et al.
Oral Oncology|August 25, 2011
Antitumor activity of cetuximab associated with the taxotere-cisplatin-fluorouracil (TPF) combination on an orthotopic head and neck cancer modelAlexandre Bozec, Anne Sudaka, Marie-Christine Etienne-Grimaldi, et al.
Oral Oncology|March 23, 2011
The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab-bevacizumab-irradiation combination on head and neck cancer xenograftsAlexandre Bozec, Marie-Christine Etienne-Grimaldi, Jean-Louis Fischel, et al.
Journal of Clinical Medicine|June 28, 2023
Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell CarcinomasRoxane Elaldi, Emmanuel Chamorey, Renaud Schiappa, et al.
Oral Oncology|October 28, 2024
Prognostic impact of intra tumoral HPV-16 viral load in oropharyngeal squamous cell carcinomasAgathe Villarmé, Nathalie Ebran, Tanguy Pace-Loscos, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 18, 2013
Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancerCédric S Pierre, Olivier Dassonville, Emmanuel Chamorey, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 7, 2023
Pathological complete response to neoadjuvant pembrolizumab in a patient with metastatic cutaneous squamous cell carcinomaManon Blaise, Gilles Poissonnet, Nathalie Cardot-Leccia, et al.
Oncotarget|June 23, 2016
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinomaYordan Benhamou, Vincent Picco, Hélène Raybaud, et al.
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expressionIvana Fantozzi, Dominique Grall, Sébastien Cagnol, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Annales De Pathologie|November 8, 2011
[Sino nasal polyps: true and false tumors]Valérie Costes, Anne Sudaka, Michel Wassef
Thyroid : Official Journal of the American Thyroid Association|September 24, 2009
Synchronous parathyroid and papillary thyroid carcinomasPierre-Yves Marcy, Juliette Thariat, Anne Sudaka, et al.
Oral Oncology|August 25, 2011
Antitumor activity of cetuximab associated with the taxotere-cisplatin-fluorouracil (TPF) combination on an orthotopic head and neck cancer modelAlexandre Bozec, Anne Sudaka, Marie-Christine Etienne-Grimaldi, et al.
Oral Oncology|March 23, 2011
The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab-bevacizumab-irradiation combination on head and neck cancer xenograftsAlexandre Bozec, Marie-Christine Etienne-Grimaldi, Jean-Louis Fischel, et al.
Journal of Clinical Medicine|June 28, 2023
Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell CarcinomasRoxane Elaldi, Emmanuel Chamorey, Renaud Schiappa, et al.
Oral Oncology|October 28, 2024
Prognostic impact of intra tumoral HPV-16 viral load in oropharyngeal squamous cell carcinomasAgathe Villarmé, Nathalie Ebran, Tanguy Pace-Loscos, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 18, 2013
Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancerCédric S Pierre, Olivier Dassonville, Emmanuel Chamorey, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 7, 2023
Pathological complete response to neoadjuvant pembrolizumab in a patient with metastatic cutaneous squamous cell carcinomaManon Blaise, Gilles Poissonnet, Nathalie Cardot-Leccia, et al.
Oncotarget|June 23, 2016
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinomaYordan Benhamou, Vincent Picco, Hélène Raybaud, et al.
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expressionIvana Fantozzi, Dominique Grall, Sébastien Cagnol, et al.
Pageof 6